3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide

C56H99N13O24 — CID 174343782

IUPAC3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide
SMILESCNC(=O)CC[C@H]1NC(=O)[C@@H](CCCCNCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(C)=O)NC(=O)CNC(=O)[C@@H](CCCCNCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](C)[C@H]2NC(C)=O)NC(=O)CNC(=O)[C@@H](CCCCNCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(C)=O)NC1=O
InChIInChI=1S/C56H99N13O24/c1-28-42(63-29(2)73)54(91-36(22-70)45(28)79)88-25-58-17-9-6-12-32-50(84)61-21-41(78)67-34(14-8-11-19-60-27-90-56-44(65-31(4)75)49(83)47(81)38(24-72)93-56)52(86)69-35(15-16-39(76)57-5)53(87)68-33(51(85)62-20-40(77)66-32)13-7-10-18-59-26-89-55-43(64-30(3)74)48(82)46(80)37(23-71)92-55/h28,32-38,42-49,54-56,58-60,70-72,79-83H,6-27H2,1-5H3,(H,57,76)(H,61,84)(H,62,85)(H,63,73)(H,64,74)(H,65,75)(H,66,77)(H,67,78)(H,68,87)(H,69,86)/t28-,32-,33-,34-,35-,36-,37-,38-,42-,43-,44-,45-,46+,47+,48-,49-,54-,55-,56-/m1/s1
InChIKeyVXEKQXMXEMHVEZ-MDZAUKHGSA-N
MW1338.47 g/mol
LogP-9.99
Rot. Bonds33

About 3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide

3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide (PubChem CID 174343782) has the molecular formula C56H99N13O24 and a molecular weight of 1338.47 g/mol. Its IUPAC name is 3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide.

Molecular Properties

Compound Name3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide
PubChem CID174343782
Molecular FormulaC56H99N13O24
Molecular Weight1338.47 g/mol
Exact Mass1337.69
IUPAC Name3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide
SMILESCNC(=O)CC[C@H]1NC(=O)[C@@H](CCCCNCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(C)=O)NC(=O)CNC(=O)[C@@H](CCCCNCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](C)[C@H]2NC(C)=O)NC(=O)CNC(=O)[C@@H](CCCCNCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(C)=O)NC1=O
InChIInChI=1S/C56H99N13O24/c1-28-42(63-29(2)73)54(91-36(22-70)45(28)79)88-25-58-17-9-6-12-32-50(84)61-21-41(78)67-34(14-8-11-19-60-27-90-56-44(65-31(4)75)49(83)47(81)38(24-72)93-56)52(86)69-35(15-16-39(76)57-5)53(87)68-33(51(85)62-20-40(77)66-32)13-7-10-18-59-26-89-55-43(64-30(3)74)48(82)46(80)37(23-71)92-55/h28,32-38,42-49,54-56,58-60,70-72,79-83H,6-27H2,1-5H3,(H,57,76)(H,61,84)(H,62,85)(H,63,73)(H,64,74)(H,65,75)(H,66,77)(H,67,78)(H,68,87)(H,69,86)/t28-,32-,33-,34-,35-,36-,37-,38-,42-,43-,44-,45-,46+,47+,48-,49-,54-,55-,56-/m1/s1
InChIKeyVXEKQXMXEMHVEZ-MDZAUKHGSA-N
XLogP-9.99
TPSA544.31 Ų
H-Bond Donors21
H-Bond Acceptors27
Rotatable Bonds33
Heavy Atoms93
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001338.47
LogP ≤ 5-9.99
H-Bond Donors ≤ 521
H-Bond Acceptors ≤ 1027

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}

Analyze 3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide?
The IUPAC name of 3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide (CID 174343782) is 3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide.
What is the SMILES notation for 3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide?
The canonical SMILES for 3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide is CNC(=O)CC[C@H]1NC(=O)[C@@H](CCCCNCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(C)=O)NC(=O)CNC(=O)[C@@H](CCCCNCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](C)[C@H]2NC(C)=O)NC(=O)CNC(=O)[C@@H](CCCCNCO[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2NC(C)=O)NC1=O.
What is the InChIKey of 3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide?
The InChIKey is VXEKQXMXEMHVEZ-MDZAUKHGSA-N. The full InChI is InChI=1S/C56H99N13O24/c1-28-42(63-29(2)73)54(91-36(22-70)45(28)79)88-25-58-17-9-6-12-32-50(84)61-21-41(78)67-34(14-8-11-19-60-27-90-56-44(65-31(4)75)49(83)47(81)38(24-72)93-56)52(86)69-35(15-16-39(76)57-5)53(87)68-33(51(85)62-20-40(77)66-32)13-7-10-18-59-26-89-55-43(64-30(3)74)48(82)46(80)37(23-71)92-55/h28,32-38,42-49,54-56,58-60,70-72,79-83H,6-27H2,1-5H3,(H,57,76)(H,61,84)(H,62,85)(H,63,73)(H,64,74)(H,65,75)(H,66,77)(H,67,78)(H,68,87)(H,69,86)/t28-,32-,33-,34-,35-,36-,37-,38-,42-,43-,44-,45-,46+,47+,48-,49-,54-,55-,56-/m1/s1.
What are the key properties of 3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide?
3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide has a molecular weight of 1338.47 g/mol, XLogP of -9.99, 33 rotatable bonds, 21 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(2R,5R,11R,17R)-5,17-bis[4-[[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylamino]butyl]-11-[4-[[(2S,3R,4R,5R,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]oxymethylamino]butyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]-N-methylpropanamide is sourced from PubChem (CID 174343782), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).